|
2023
|
Invention
|
Compositions of trofinetide. This disclosure describes compounds of Formula (I), stereoisomers, s... |
|
2022
|
Invention
|
Process for preparing bicyclic glycine-proline compounds and monocyclic glycine-proline intermedi... |
|
|
Invention
|
Treatments of prader-willi syndrome.
The present disclosure generally relates to methods of and ... |
|
|
Invention
|
Treatments of prader-willi syndrome. The present disclosure generally relates to methods of and u... |
|
|
Invention
|
Methods and compositions for treatment of rett syndrome.
Disclosed herein are methods of treatin... |
|
2020
|
Invention
|
Methods and compositions for treatment of rett syndrome. Disclosed herein are methods of treating... |
|
|
Invention
|
Bicyclic compounds and methods for their use in treating pitt hopkins syndrome. Embodiments of th... |
|
|
Invention
|
Bicyclic compounds and methods for their use in treating autism. Embodiments of this invention pr... |
|
2018
|
Invention
|
Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevel... |
|
2016
|
Invention
|
Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorder... |
|
2015
|
Invention
|
Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals.
Embodiments of... |
|
|
Invention
|
Treatment of autism spectrum disorders using glycyl-l-2-methylprolyl-l-glumatic acid.
This inven... |
|
|
Invention
|
Treatment of rett syndrome using glycyl-l-2-methylprolyl-l-glutamic acid. This invention provides... |
|
2014
|
Invention
|
Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals. Embodiments of ... |
|
2013
|
Invention
|
Treatment of autism spectrum disorders using glycyl-l-2-methylprolyl-l-glutamic acid. This invent... |
|
2012
|
Invention
|
Antibodies that bind trefoil factors and methods of using same. The invention relates generally t... |
|
|
Invention
|
Treatment of autism spectrum disorderes using glycyl-l-2-methylprolyl-l-glutamic acid. This inven... |
|
2010
|
Invention
|
Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy. Embodiments of t... |
|
2009
|
Invention
|
Conformation specific antibodies that bind trefoil factors.
The present invention relates to con... |
|
|
Invention
|
Conformation specific antibodies that bind trefoil factors. Conformation specific antibodies to T... |
|
2008
|
Invention
|
Synthetic analogues of neural regeneration peptides. Embodiments of this invention include synthe... |
|
2007
|
Invention
|
Conformation specific antibodies that bind trefoil factors and methods of treating cancers and pr... |
|
|
Invention
|
Oral formulations of glycyl-2-methylprolyl-glutamate. Oral formulations of G-2MePE including micr... |
|
|
Invention
|
Infusion pump. Embodiments of this invention include implantable pumps for delivery of solutions ... |
|
2006
|
Invention
|
Methods for detecting weakly immunogenic analytes. GPE antibodies recognize GPE with high specifi... |
|
|
Invention
|
Neuroprotective effect of activin in animals exposed to hypoxia/ischemia.
This invention include... |
|
|
Invention
|
Neural regeneration peptides and antioxidants protect neurons from degeneration. Aspects of this ... |
|
|
Invention
|
Analogs of glycyl-prolyl-glutamate. Embodiments of this invention include novel analogs of Glycyl... |
|
|
Invention
|
Neural regeneration peptides and methods for their use |
|
2005
|
Invention
|
Trefoil factors and methods of treating proliferation disorders using same. The present invention... |
|
|
Invention
|
Cognitive enhancement and cognitive therapy using glycyl-l-2-methylprolyl-l-glutamate.
This inve... |
|
|
Invention
|
Non-diabetogenic therapy using a 20kda placental growth hormone variant. Embodiments of the prese... |
|
|
Invention
|
Gpe and g-2mepe, caffeine and alkanol for treatment of cns injury. This invention includes compos... |
|
2004
|
Invention
|
Neural regeneration peptides and methods of use. The invention discloses a family of peptides ter... |
|
|
Invention
|
Neuroprotective effects of gly-pro-glu following intravenous infusion.
Gly-Pro-Glu (GPE) is rapi... |
|
|
Invention
|
Anti-gpe antibodies, their uses and assays for weakly immunogenic molecules.
Anti-GPE antibodies... |
|
|
Invention
|
Neuroprotective effects of gly-pro-glu following intravenous infusion. Gly-Pro-Glu (GPE) is rapid... |
|
|
Invention
|
Neuroprotective bicyclic compounds and methods for their use. Embodiments of this invention provi... |
|
|
Invention
|
Somatogenic therapy using a 20kda placental variant of growth hormone.
Embodiments of the presen... |
|
|
Invention
|
Somatogenic therapy using a 20kda placental variant of growth hormone. Embodiments of the present... |
|
|
Invention
|
Neuroprotective macrocylic compounds and methods for their use. Embodiments of this invention pro... |
|
2003
|
Invention
|
Regulation of tyrosine hydroxylase by gpe. Embodiments of this invention include methods for incr... |
|
2002
|
Invention
|
Neuroprotective effect of growth hormone. The invention relates to neuroprotection and to medicam... |
